Shanghai Junshi Biosciences Co., Ltd. (1877.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 19.27B |
| Enterprise Value | 20.79B |
| P/E Ratio | -54.48 |
| PEG Ratio | -0.75 |
| Price/Sales Ratio | 13.24 |
| Price/Book Ratio | 6.16 |
| Enterprise/Revenue | 14 |
| Enterprise/EBITDA | -66.79 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.24 |
| Operating Margin | -0.3 |
AD
Management Effectiveness
| Return On Assets | -0.05 |
| Return On Equity | -0.11 |
Income Statement
| Revenue | 2.43B |
| Revenue/Share | 2.66 |
| Gross Profit | 1.97B |
| EBITDA | -599.38M |
| Net Income | -851.76M |
| Diluted EPS | -0.84 |
Balance Sheet
| Total Cash | 4.55B |
| Total Cash/Share | 4.45 |
| Total Debt | 5.96B |
| Total Debt/Equity | 1.01 |
| Current Ratio | 2.14 |
| Book Value Per Share | 5.94 |
Price History
| 52-Week Change | -25.73 |
| 52-Week High | 38.64 |
| 52-Week Low | 15.25 |
| Moving Average 50 Days | 18.49 |
| Moving Average 200 Days | 22.35 |
Statistics
| Average Volume | 3.68M |
| Shares Outstanding | 1.41B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.15 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
